Simplex Trading
ELTX icon

Simplex Trading’s Elicio Therapeutics ELTX Stock Holding History

Simplex Trading’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$482K Buy
45,100
+43,700
+3,121% +$422K ﹤0.01% 3307
2025
Q4 		$11.1K Buy
1,400
+300
+27% +$2.72K ﹤0.01% 6917
2025
Q3 		$12K Hold
1,100
– – ﹤0.01% 7746
2025
Q2 		$1K Buy
+1,100
New +$6.84K ﹤0.01% 8301

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Simplex Trading's ELTX Position: Q4 2025 in Review

Simplex Trading sold out of Elicio Therapeutics (ELTX) in Q4 2025, closing a stake of 103 shares — an estimated $935 sold.

Simplex Trading first reported a position in ELTX in Q3 2025 and held it in 1 quarter. The position peaked at $1K in Q3 2025. 37 funds tracked by Wall St. Rank hold ELTX as of Q4 2025.

  • Simplex Trading reported no remaining Elicio Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 103 Elicio Therapeutics shares in Q4 2025, an estimated $935.
  • Simplex Trading first reported a position in Elicio Therapeutics in Q3 2025 and held it in 1 quarter.
  • Simplex Trading's Elicio Therapeutics position peaked at $1K in Q3 2025.
  • 37 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.